OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid ยท OpenFeds ยท OpenSpending

ยฉ 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodologyโ€ขDownload Data
  1. Home
  2. Providers
  3. Kishore Sehgal
๐ŸŽ—๏ธ
MDIndividual

Kishore Sehgal, M.D.

NPI: 1689671034
Hemet, CA
10 years of data
Hematology-Oncology
$36.2M
Total Payments
411
Beneficiaries
2.6M
Services
1.72x
Markup Ratio

Peer Comparison

99th
percentile in specialty
This provider$36.2M
Specialty median$339.6K
Rank #42 of 60 in specialty

๐Ÿ“‹ Key Findings

1Billed $36.2M over 10 years
21.72x markup ratio
399th percentile in Hematology-Oncology by payments
41.1K services/day โ€” physically implausible

โš ๏ธ This provider averages 1.1K services per working day โ€” physically unusual for an individual practitioner

Based on 2.6M total services over 10 years (250 working days/year). Learn about impossible service volumes โ†’

๐Ÿ”Ž Data Analysis

This provider's $36.2M in total Medicare payments ranks in the 99th percentile of Hematology-Oncology providers nationally.

Averaging 1.1K services per working day raises questions about billing patterns.

Medicare payments to this provider grew 74% from 2014 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid โ€” the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2014$22.76$12.991.75x$9.77$2.3M180.1K40
2015$15.30$9.131.68x$6.17$2.0M214.5K39
2016$30.77$15.511.98x$15.26$2.6M164.6K39
2017$24.62$13.101.88x$11.52$3.1M236.0K38
2018$32.15$18.221.76x$13.93$4.6M253.9K47
2019$23.26$12.291.89x$10.97$4.4M356.7K46
2020$21.17$13.741.54x$7.43$5.5M400.5K42
2021$28.84$18.001.60x$10.84$4.2M231.4K41
2022$25.05$15.251.64x$9.80$3.5M232.7K38
2023$18.61$11.511.62x$7.10$4.1M353.5K41

Top Procedures (20)

J9271Injection, pembrolizumab, 1 mg
$7.0M
171.8K services$40.63/svc1.40x markup
J9299Injection, nivolumab, 1 mg
$2.6M
118.8K services$21.93/svc1.44x markup
J9145Injection, daratumumab, 10 mg
$1.6M
39.0K services$41.21/svc1.48x markup
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj
$1.6M
42.3K services$36.93/svc1.66x markup
J9310Injection, rituximab, 100 mg
$1.5M
2.5K services$609.96/svc1.47x markup
99214Established patient office or other outpatient visit, 30-39 minutes
$1.5M
17.6K services$86.17/svc1.37x markup
J9264Injection, paclitaxel protein-bound particles, 1 mg
$1.5M
156.6K services$9.29/svc1.57x markup
J9035Injection, bevacizumab, 10 mg
$1.4M
24.1K services$56.31/svc1.56x markup
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units
$1.3M
147.1K services$9.04/svc2.30x markup
J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
$1.2M
41.7K services$29.93/svc2.84x markup
J9041Injection, bortezomib, 0.1 mg
$1.2M
42.3K services$29.07/svc1.97x markup
J9355Injection, trastuzumab, 10 mg
$1.1M
15.6K services$69.96/svc1.53x markup
96413Administration of chemotherapy into vein, 1 hour or less
$898.8K
7.7K services$116.26/svc1.27x markup
J9305Injection, pemetrexed, not otherwise specified, 10 mg
$731.1K
13.0K services$56.15/svc1.46x markup
J1556Injection, immune globulin (bivigam), 500 mg
$711.0K
12.7K services$56.21/svc1.42x markup
Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
$682.5K
96.4K services$7.08/svc2.06x markup
J2505Injection, pegfilgrastim, 6 mg
$614.7K
203 services$3.0K/svc1.84x markup
J2820Injection, sargramostim (gm-csf), 50 mcg
$584.7K
21.0K services$27.85/svc2.00x markup
J0897Injection, denosumab, 1 mg
$475.3K
31.5K services$15.09/svc1.44x markup
J9173Injection, durvalumab, 10 mg
$466.2K
7.7K services$60.44/svc1.55x markup
Show detailed table โ–พ
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
J9271Injection, pembrolizumab, 1 mg171.8K$7.0M$40.631.40x
J9299Injection, nivolumab, 1 mg118.8K$2.6M$21.931.44x
J9145Injection, daratumumab, 10 mg39.0K$1.6M$41.211.48x
J9144Injection, daratumumab, 10 mg and hyaluronidase-fihj42.3K$1.6M$36.931.66x
J9310Injection, rituximab, 100 mg2.5K$1.5M$609.961.47x
99214Established patient office or other outpatient visit, 30-39 minutes17.6K$1.5M$86.171.37x
J9264Injection, paclitaxel protein-bound particles, 1 mg156.6K$1.5M$9.291.57x
J9035Injection, bevacizumab, 10 mg24.1K$1.4M$56.311.56x
J0885Injection, epoetin alfa, (for non-esrd use), 1000 units147.1K$1.3M$9.042.30x
J1568Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg41.7K$1.2M$29.932.84x
J9041Injection, bortezomib, 0.1 mg42.3K$1.2M$29.071.97x
J9355Injection, trastuzumab, 10 mg15.6K$1.1M$69.961.53x
96413Administration of chemotherapy into vein, 1 hour or less7.7K$898.8K$116.261.27x
J9305Injection, pemetrexed, not otherwise specified, 10 mg13.0K$731.1K$56.151.46x
J1556Injection, immune globulin (bivigam), 500 mg12.7K$711.0K$56.211.42x
Q5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units96.4K$682.5K$7.082.06x
J2505Injection, pegfilgrastim, 6 mg203$614.7K$3.0K1.84x
J2820Injection, sargramostim (gm-csf), 50 mcg21.0K$584.7K$27.852.00x
J0897Injection, denosumab, 1 mg31.5K$475.3K$15.091.44x
J9173Injection, durvalumab, 10 mg7.7K$466.2K$60.441.55x

Markup Analysis

Charge-to-Payment Ratio

1.72x

This provider submits charges 1.72 times higher than what Medicare actually pays.

What This Means

A markup ratio of 1.72x means for every $100 Medicare pays, this provider initially charges $172. This is lower than the national average.

Location

Hemet, CA

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Similar Providers

Other Hematology-Oncology providers in CA for peer comparison.

Kishore Sehgal (you)
$36.2M
Luke Dreisbach, M.D.
$77.2M
Sachin Gupta, M.D.
$55.1M
Ravi Rao, MDโš ๏ธ
$49.1M
Michael Sherman, M.D., PHD
$38.9M
Nerses Tchekmedyian, M.D.
$38.0M
Show detailed table โ–พ
ProviderLocationTotal PaymentsStatus
Luke Dreisbach, M.D.Rancho Mirage, CA$77.2Mโœ“ Clear
Sachin Gupta, M.D.Fresno, CA$55.1Mโœ“ Clear
Ravi Rao, MDFresno, CA$49.1Mโš ๏ธ Flagged
Michael Sherman, M.D., PHDWalnut Creek, CA$38.9Mโœ“ Clear
Nerses Tchekmedyian, M.D.Irvine, CA$38.0Mโœ“ Clear

Related

Browse
โ† Back to Provider Directory
State
All providers in CA โ†’
Specialty
All Hematology-Oncology providers โ†’
Tool
Compare this provider โ†’
Analysis
Fraud Watchlist โ†’
Search
Search all providers โ†’

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • โ€ข Centers for Medicare & Medicaid Services (CMS)
  • โ€ข Medicare Provider Utilization and Payment Data (2014-2023)
  • โ€ข National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data